CytaCoat AB is a private Swedish company located in the Karolinska Institutet Science Park AB in Solna (Stockholm area). CytaCoat has developed a unique, stable and universal anti-biofilm coating for prevention of Healthcare-Associated Infections (HAIs) related with the use of invasive and non-invasive medical devices. This strong chemical bond in the anti-fouling coating provides stability and prevents the release of components with potential toxic or accumulation effects in the patient. This avoids the use of antibiotics and the ability of bacteria to develop resistance. The strategy is to sell the technology and defined protocol to medical device manufacturing companies via collaborations (OEM) and out-licensing deals.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
What industry is CytaCoat in?
CytaCoat operates in Research Services. Find similar Research Services investors on gritt.io.
Where is CytaCoat based?
CytaCoat is headquartered in Solna, Sweden.
Find investors for your startup like CytaCoat
Gritt sends AI-personalised outreach to each investor — from your Gmail
